IBDEI0TU ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13426,2)
 ;;=^5006142
 ;;^UTILITY(U,$J,358.3,13427,0)
 ;;=M31.6^^51^636^19
 ;;^UTILITY(U,$J,358.3,13427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13427,1,3,0)
 ;;=3^Giant Cell Arteritis,Other
 ;;^UTILITY(U,$J,358.3,13427,1,4,0)
 ;;=4^M31.6
 ;;^UTILITY(U,$J,358.3,13427,2)
 ;;=^5011748
 ;;^UTILITY(U,$J,358.3,13428,0)
 ;;=H53.47^^51^636^26
 ;;^UTILITY(U,$J,358.3,13428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13428,1,3,0)
 ;;=3^Heteronymous Bilateral Field Defects
 ;;^UTILITY(U,$J,358.3,13428,1,4,0)
 ;;=4^H53.47
 ;;^UTILITY(U,$J,358.3,13428,2)
 ;;=^268847
 ;;^UTILITY(U,$J,358.3,13429,0)
 ;;=H53.462^^51^636^25
 ;;^UTILITY(U,$J,358.3,13429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13429,1,3,0)
 ;;=3^Homonymous Bilateral Field Defects,Left Side
 ;;^UTILITY(U,$J,358.3,13429,1,4,0)
 ;;=4^H53.462
 ;;^UTILITY(U,$J,358.3,13429,2)
 ;;=^5006342
 ;;^UTILITY(U,$J,358.3,13430,0)
 ;;=H53.461^^51^636^24
 ;;^UTILITY(U,$J,358.3,13430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13430,1,3,0)
 ;;=3^Homonymous Bilateral Field Defects,Right Side
 ;;^UTILITY(U,$J,358.3,13430,1,4,0)
 ;;=4^H53.461
 ;;^UTILITY(U,$J,358.3,13430,2)
 ;;=^5006341
 ;;^UTILITY(U,$J,358.3,13431,0)
 ;;=H47.013^^51^636^9
 ;;^UTILITY(U,$J,358.3,13431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13431,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Bilateral
 ;;^UTILITY(U,$J,358.3,13431,1,4,0)
 ;;=4^H47.013
 ;;^UTILITY(U,$J,358.3,13431,2)
 ;;=^5006107
 ;;^UTILITY(U,$J,358.3,13432,0)
 ;;=H47.011^^51^636^7
 ;;^UTILITY(U,$J,358.3,13432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13432,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Right Eye
 ;;^UTILITY(U,$J,358.3,13432,1,4,0)
 ;;=4^H47.011
 ;;^UTILITY(U,$J,358.3,13432,2)
 ;;=^5006105
 ;;^UTILITY(U,$J,358.3,13433,0)
 ;;=H47.012^^51^636^8
 ;;^UTILITY(U,$J,358.3,13433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13433,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Left Eye
 ;;^UTILITY(U,$J,358.3,13433,1,4,0)
 ;;=4^H47.012
 ;;^UTILITY(U,$J,358.3,13433,2)
 ;;=^5006106
 ;;^UTILITY(U,$J,358.3,13434,0)
 ;;=H47.233^^51^636^6
 ;;^UTILITY(U,$J,358.3,13434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13434,1,3,0)
 ;;=3^Optic Atrophy,Glaucomatous,Bilateral
 ;;^UTILITY(U,$J,358.3,13434,1,4,0)
 ;;=4^H47.233
 ;;^UTILITY(U,$J,358.3,13434,2)
 ;;=^5006133
 ;;^UTILITY(U,$J,358.3,13435,0)
 ;;=H47.231^^51^636^4
 ;;^UTILITY(U,$J,358.3,13435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13435,1,3,0)
 ;;=3^Optic Atrophy,Glaucomatous,Right Eye
 ;;^UTILITY(U,$J,358.3,13435,1,4,0)
 ;;=4^H47.231
 ;;^UTILITY(U,$J,358.3,13435,2)
 ;;=^5006131
 ;;^UTILITY(U,$J,358.3,13436,0)
 ;;=H47.232^^51^636^5
 ;;^UTILITY(U,$J,358.3,13436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13436,1,3,0)
 ;;=3^Optic Atrophy,Glaucomatous,Left Eye
 ;;^UTILITY(U,$J,358.3,13436,1,4,0)
 ;;=4^H47.232
 ;;^UTILITY(U,$J,358.3,13436,2)
 ;;=^5006132
 ;;^UTILITY(U,$J,358.3,13437,0)
 ;;=H46.9^^51^636^19
 ;;^UTILITY(U,$J,358.3,13437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13437,1,3,0)
 ;;=3^Optic Neuritis,Unspec
 ;;^UTILITY(U,$J,358.3,13437,1,4,0)
 ;;=4^H46.9
 ;;^UTILITY(U,$J,358.3,13437,2)
 ;;=^5006104
 ;;^UTILITY(U,$J,358.3,13438,0)
 ;;=H46.03^^51^636^15
 ;;^UTILITY(U,$J,358.3,13438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13438,1,3,0)
 ;;=3^Optic Papillitis,Bilateral
 ;;^UTILITY(U,$J,358.3,13438,1,4,0)
 ;;=4^H46.03
 ;;^UTILITY(U,$J,358.3,13438,2)
 ;;=^5006099
